Promonitor Quick

A point-of-care test (starting from whole blood or serum) that allows clinicians to detect infliximab and anti-infliximab antibodies in a quick and fully decentralized mode, facilitating immediate decisions.

OVERVIEW

Personalized Medicine

The tool to facilitate immediate decisions.

• Promonitor Quick is a set of rapid immunochromatography tests that allow the clinician to measure drug levels and anti-drug antibody levels in a quick and fully decentralized way

Easy to Use

Easy protocol with minimal steps.

• 4 simple steps
• Results in 20 minutes
• Fully decentralized, real point-of-care (POC)
• Starting from whole blood

Biosimilars

Ready for the new emerging market players.

• Promonitor Quick kits are able to quantify the reference infliximab and the following biosimilars and the corresponding anti-infliximab antibodies: CT-P13, SB2, and GP1111

Reliability

Reliable and accurate detection in either venous, serum, or capillary circulation (fingerstick).

• Results show an almost perfect match between specimens and the reference ELISA technique

Treatments

Intravenous and subcutaneous treatments.

• Promonitor Quick IFX allows quantification of a broad range of concentrations, facilitating monitoring of intravenous and subcutaneous treatments